NKG2D is the most typical activating receptor on NK cells with the ability to recognize the structural analogs of MHC-I like ULBP and MICA/B, which can be upregulated through infection, stress, and tumor cells, and plays a critical role in processing tumor immune surveillance [54]. The gene discussed is KLRK1; the disease is neoplasm.